Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Q32 Bio (QTTB) Net Margin (2018 - 2023)

Q32 Bio (QTTB) has 6 years of Net Margin data on record, last reported at 567.46% in Q4 2023.

  • For Q4 2023, Net Margin rose 467444.0% year-over-year to 567.46%; the TTM value through Sep 2024 reached 42.98%, up 63271.0%, while the annual FY2025 figure was 31.45%, N/A changed from the prior year.
  • Net Margin reached 567.46% in Q4 2023 per QTTB's latest filing, up from 751.26% in the prior quarter.
  • Across five years, Net Margin topped out at 11558.1% in Q1 2022 and bottomed at 8834.07% in Q1 2019.
  • Average Net Margin over 5 years is 2727.31%, with a median of 3591.33% recorded in 2022.
  • Peak YoY movement for Net Margin: surged 1156177bps in 2022, then crashed -1179014bps in 2023.
  • A 5-year view of Net Margin shows it stood at 4292.54% in 2019, then rose by 29bps to 3039.8% in 2020, then crashed by -38bps to 4187.41% in 2021, then rose by 2bps to 4106.98% in 2022, then soared by 114bps to 567.46% in 2023.
  • Per Business Quant database, its latest 3 readings for Net Margin were 567.46% in Q4 2023, 751.26% in Q3 2023, and 181.19% in Q2 2023.